The above chart presents the market trend analysis for zhejiang yongning pharmaceutical co.ltd. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 1 transactions, with a transaction quantity of 20 and a transaction weight of 0.
YearTransactionsQuantityWeight
20245450100
20251200
Bill of lading data
<
1/15
>
Trade date
2025/03/06
B/L No.
106992630510
Suppliers
zhejiang yongning pharmaceutical co.ltd.
Buyers
công ty cổ phần hóa dược phẩm mekophar
Product description
PHARMACEUTICAL RAW MATERIALS: CEFOTIAM HYDROCHLORIDE AND SODIUM CARBONATE (IN HOUSE), MANUFACTURER: ZHEJIANG YONGNING PHARMACEUTICAL CO.,LTD. LOT NUMBER: 2310101, PRODUCTION: OCTOBER 2023_SEPTEMBER 2025
Expand
Trade date
2023/09/23
B/L No.
——
Suppliers
zhejiang yongning pharmaceutical co.ltd.
Buyers
minh dan pharmaceutical joint stock co
Product description
CEFOTIAM HYDROCHLORIDE AND SODIUM CARBONATE HÀNG MỚI 100% NL SẢN XUẤT THUỐC.TIÊU CHUẨN IN HOUSE-LÔ:2103110- NSX 03/2021- HD:02/2023- NHA SX:ZHEJIANG YONGNING PHARMACEUTICAL CO., LTD @
Expand
zhejiang yongning pharmaceutical co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as ceftriaxone sodium,entercavir,neomycin sulphate.
According to the 52wmb.com global trade database, as of 2025-03-06, the company has completed 95 international trades,
with its main trading regions covering vietnam,pakistan,ukraine etc.
The core products include HS29419000 etc,
often transported via shanghai,port bkk, port ua а п бориспіль etc,
and its main trading partners are ват київмедпрепарат,tabros phapma,aceto.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on zhejiang yongning pharmaceutical co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.